1 Min Read
Sept 28 (Reuters) - Chembio Diagnostics Inc
* Chembio Diagnostics receives FDA emergency use authorization for the first rapid Zika Igm test Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.